Immunic, Inc. (IMUX) Capital expenditures 2016–2025
Immunic, Inc. (IMUX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$161,000FY2025 · since FY2016: $556,000 → $161,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $161,000 | -39.0% |
| FY2024 | $264,000 | -21.0% |
| FY2023 | $334,000 | +198.2% |
| FY2022 | $112,000 | +67.2% |
| FY2021 | $67,000 | -54.1% |
| FY2020 | $146,000 | +165.5% |
| FY2019 | $55,000 | +71.9% |
| FY2018 | $32,000 | -95.3% |
| FY2017 | $685,000 | +23.2% |
| FY2016 | $556,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice